James E Loyd Selected Research

James E Loyd Research Topics

Disease

23	Pulmonary Arterial Hypertension 01/2020 - 02/2003
14	Idiopathic Pulmonary Fibrosis 12/2022 - 01/2002
13	Familial Primary Pulmonary Hypertension 05/2017 - 03/2002
8	Pulmonary Hypertension 01/2019 - 04/2007
5	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 04/2005
5	Fibrosis (Cirrhosis) 01/2019 - 04/2005
4	Mediastinal Fibrosis 05/2015 - 08/2007
3	Cytomegalovirus Infections (Inclusion Disease) 01/2021 - 02/2002
3	Vascular Remodeling 01/2019 - 04/2012
3	Asthma (Bronchial Asthma) 12/2018 - 04/2012
3	Inflammation (Inflammations) 01/2018 - 04/2012
3	Hereditary Hemorrhagic Telangiectasia 10/2014 - 06/2009
2	Hypertrophy 12/2021 - 10/2015
2	Right Ventricular Hypertrophy 01/2019 - 10/2015
2	Hypoxia (Hypoxemia) 01/2019 - 10/2015
2	Insulin Resistance 01/2017 - 09/2013
2	Histoplasmosis 05/2015 - 10/2007
2	Genetic Anticipation 11/2012 - 08/2009
2	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2011 - 05/2002
2	Infections 08/2009 - 02/2002
2	Congenital Heart Defects (Congenital Heart Defect) 06/2009 - 07/2004
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 12/2022
1	Exanthema (Rash) 01/2021
1	Cystic Fibrosis (Mucoviscidosis) 12/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2018
1	Sepsis (Septicemia) 12/2018
1	Lung Diseases (Lung Disease) 12/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2018
1	Lung Neoplasms (Lung Cancer) 12/2018
1	Neointima 10/2015
1	Iron Deficiencies 08/2015
1	Neoplasms (Cancer) 04/2014
1	Vascular System Injuries 09/2013
1	Stroke (Strokes) 08/2013
1	Airway Remodeling 04/2012
1	Type 2 Diabetes Mellitus (MODY) 12/2011
1	Gastroesophageal Reflux (GERD) 12/2011

Drug/Important Bio-Agent (IBA)

9	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2016 - 10/2006
7	Proteins (Proteins, Gene)FDA Link 10/2015 - 03/2002
6	hydralazine 4-anisaldehyde hydrazoneIBA 01/2016 - 06/2009
4	Caveolin 1IBA 01/2020 - 10/2015
4	Transforming Growth Factor beta (TGF-beta)IBA 06/2012 - 06/2004
4	Surface-Active Agents (Surfactants)IBA 04/2010 - 05/2002
3	CollagenIBA 12/2021 - 04/2005
3	Bleomycin (Blenoxane)FDA LinkGeneric 06/2017 - 04/2005
3	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 01/2016 - 03/2003
3	ProstaglandinsIBA 08/2013 - 01/2002
3	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2011 - 03/2007
3	Protein CIBA 04/2010 - 05/2002
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 04/2007 - 01/2002
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 04/2012
2	Adenine FDA LinkGeneric 05/2017 - 03/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017 - 10/2015
2	Estrogens (Estrogen)FDA Link 01/2016 - 09/2013
2	telomerase RNA (bTR)IBA 01/2016 - 03/2007
2	activin receptor type II-A (activin A receptor, type II)IBA 10/2014 - 12/2013
2	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2012 - 04/2012
2	EndoglinIBA 06/2012 - 06/2009
2	Ganciclovir (Cytovene)FDA LinkGeneric 08/2009 - 02/2002
1	Valganciclovir FDA Link 01/2021
1	pirfenidoneIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	enzastaurinIBA 01/2019
1	Angiotensin-Converting Enzyme 2IBA 01/2018
1	alunacedase alfaIBA 01/2018
1	Blood Proteins (Serum Proteins)IBA 01/2018
1	CateninsIBA 06/2017
1	LipidsIBA 01/2017
1	Desmoplakins (Desmoplakin)IBA 01/2016
1	MonocrotalineIBA 10/2015
1	Caveolin 2IBA 10/2015
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2015
1	M40 (M 40)IBA 10/2015
1	IronIBA 08/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2015
1	EndostatinsIBA 01/2015
1	Estrogen ReceptorsIBA 09/2013
1	Mucin-5BIBA 06/2013
1	Activin Receptors (Activin Receptor)IBA 06/2012
1	CytokinesIBA 04/2012
1	Histamine (Histamine Dihydrochloride)FDA Link 04/2012
1	9- hydroxy- 11,15- dioxo- 2,3,18,19- tetranorprost- 5- ene- 1,20- dioic acidIBA 04/2012
1	Tryptases (Tryptase)IBA 04/2012
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2012
1	LeukotrienesIBA 04/2012
1	GasesIBA 12/2011
1	MetalsIBA 12/2011
1	P-2 (P 2)IBA 04/2011
1	MucinsIBA 04/2011
1	Reticulin (Reticular Fiber)IBA 03/2011
1	Hypoxia-Inducible Factor 1IBA 03/2011

Therapy/Procedure

9	Therapeutics 01/2021 - 06/2006
3	Lung Transplantation 12/2022 - 02/2002
2	Precision Medicine 12/2018 - 12/2015
2	Stents 04/2011 - 06/2003
1	Contraindications 12/2016
1	Aftercare (After-Treatment) 08/2013
1	Heart-Lung Transplantation 08/2009